DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy
Open Access
- 1 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Data
- Vol. 7 (1), 1-10
- https://doi.org/10.1038/s41597-020-0456-0
Abstract
Acquired resistance to chemotherapy is an important clinical problem and can also occur without detectable cytogenetic aberrations or gene mutations. Chronic lymphocytic leukemia (CLL) is molecularly well characterized and has been elemental for establishing central paradigms in oncology. This prompted us to check whether specific epigenetic changes at the level of DNA methylation might underlie development of treatment resistance. We used Illumina Infinium HumanMethylation450 BeadChips to obtain DNA methylation profiles of 71 CLL patients with differential responses. Thirty-six patients were categorized as relapsed/refractory after treatment with fludarabine or bendamustine and 21 of them had genetic aberrations of TP53. The other 35 patients were untreated at the time of sampling and 15 of them had genetic aberration of TP53. Although we could not correlate chemoresistance with epigenetic changes, the patients were comprehensively characterized regarding relevant prognostic and molecular markers (e.g. IGHV mutation status, chromosome aberrations, TP53 mutation status, clinical parameters), which makes our dataset a unique and valuable resource that can be used by researchers to test alternative hypotheses.Funding Information
- Helmholtz Association (VH-VI-404)
This publication has 34 references indexed in Scilit:
- First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trialThe Lancet Oncology, 2016
- Chronic lymphocytic leukemia (CLL)—Then and nowAmerican Journal of Hematology, 2016
- Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trialBlood, 2016
- Non-specific filtering of beta-distributed dataBMC Bioinformatics, 2014
- Low-level processing of Illumina Infinium DNA Methylation BeadArraysNucleic Acids Research, 2013
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damageBlood, 2009
- Replication in Genome-Wide Association StudiesStatistical Science, 2009
- Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trialBlood, 2009
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaThe New England Journal of Medicine, 2000